RIETE_Score_Risk_Hemorrhage_Pulmonary_Embolism_Treatment v.1
RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment determine the risk of major bleeding during anticoagulant therapy.
To determine the risk of major bleeding during anticoagulant therapy.
Risk Factor Point Value Recent Major Bleeding 2 Cr > 1.2 mg/dL 1.5 Anemia 1.5 Cancer 1 Clinically-overt PE 1 Age >75 1 The study used 0 points to define low risk for major bleeding events (0.1% risk of bleeding), 1-4 points for intermediate risk (2.8% risk), and >4 points for high risk (6.2% risk).
1. Ruíz-Giménez N, Suárez C, González R, Nieto JA, Todolí JA, Samperiz AL, Monreal M; RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.Thromb Haemost. 2008 Jul;100(1):26-31.
OBSERVATION.basic_demographic.v1, EVALUATION.riete_score_for_risk_hemorrhage_pulmonary_embolism_treatment.v0, OBSERVATION.lab_test_creatinine.v1, OBSERVATION.lab_test-full_blood_count.v1
